Wellington Management Group LLP Verve Therapeutics, Inc. Transaction History

Wellington Management Group LLP

$557 Billion
Q3 2024

A detailed history of Wellington Management Group LLP transactions in Verve Therapeutics, Inc. stock. As of the latest transaction made, Wellington Management Group LLP holds 347,029 shares of VERV stock, worth $2.48 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

347,029

Previous 371,300 6.54%

Holding current value

$2.48 Million

Previous $1.81 Million 7.29%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$4.4 - $7.86 $106,792 - $190,770	-24,271 Reduced 6.54%	347,029 $1.68 Million
Q2 2024 Aug 13, 2024	BUY	$4.76 - $12.79 $562,946 - $1.51 Million	118,266 Added 46.74%	371,300 $1.81 Million
Q1 2024 May 15, 2024	BUY	$10.81 - $17.96 $2.74 Million - $4.54 Million	253,034 New	253,034 $3.36 Million
Q4 2023 Feb 12, 2024	BUY	$8.84 - $18.7 $1.39 Million - $2.94 Million	157,241 New	157,241 $2.19 Million
Q3 2023 Nov 14, 2023	SELL	$11.42 - $20.82 $2.1 Million - $3.82 Million	-183,602 Reduced 18.81%	792,526 $10.5 Million
Q2 2023 Aug 14, 2023	BUY	$13.34 - $19.9 $573,099 - $854,923	42,961 Added 4.6%	976,128 $18.3 Million
Q1 2023 May 12, 2023	BUY	$14.3 - $24.01 $1.06 Million - $1.78 Million	74,065 Added 8.62%	933,167 $13.5 Million
Q4 2022 Feb 13, 2023	SELL	$17.85 - $40.7 $2.71 Million - $6.17 Million	-151,606 Reduced 15.0%	859,102 $16.6 Million
Q3 2022 Nov 14, 2022	SELL	$15.63 - $41.49 $3.95 Million - $10.5 Million	-252,676 Reduced 20.0%	1,010,708 $34.7 Million
Q2 2022 Aug 15, 2022	SELL	$11.14 - $23.17 $12.1 Million - $25.1 Million	-1,082,663 Reduced 46.15%	1,263,384 $19.3 Million
Q1 2022 May 16, 2022	SELL	$20.92 - $39.36 $33.3 Million - $62.7 Million	-1,593,461 Reduced 40.45%	2,346,047 $53.5 Million
Q4 2021 Feb 11, 2022	SELL	$31.94 - $54.82 $20.9 Million - $35.9 Million	-654,718 Reduced 14.25%	3,939,508 $145 Million
Q3 2021 Nov 15, 2021	BUY	$46.0 - $73.99 $28.9 Million - $46.5 Million	628,747 Added 15.86%	4,594,226 $214 Million
Q2 2021 Aug 16, 2021	BUY	$31.92 - $60.25 $127 Million - $239 Million	3,965,479 New	3,965,479 $232 Million

Others Institutions Holding VERV

# of Institutions

186

Shares Held

73.3M

Call Options Held

85K

Put Options Held

215K

View Full List

About Verve Therapeutics, Inc.

Ticker VERV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,942,300
Market Cap $429M
Description
Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development of ANGPTL3 program t...

More about VERV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.

Account

Wellington Management Group LLP Verve Therapeutics, Inc. Transaction History